Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC)	Small Cell Lung Cancer Extensive Stage	Active, not recruiting	Phase 2	2026-08-11		NCT05856695

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Intergroupe Francophone de Cancerologie Thoracique	15

31 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Abbeville - CH	Abbeville	France	1
Amiens - Clinique de l'Europe	Amiens	France	3
Angers - CHU	Angers	France	9
Annemasse - CH	Contamine-sur-Arve	France	1
Besançon - CHU	Besançon	France	7
Bordeaux - CHU	Bordeaux	France	2
Boulogne - Ambroise Paré	Boulogne-Billancourt	France	3
Caen - CHU Côte de Nacre	Caen	France	6
Chambéry - CH	Chambéry	France	1
Cholet - CH	Cholet	France	3
CHU Montpellier	Montpellier	France	23
CHU Toulouse	Toulouse	France	19
Colmar - CH	Colmar	France	4
Créteil - CHI	Créteil	France	6
Dijon - CHU Bocage	Dijon	France	4
Grenoble - CHU	Grenoble	France	7
Le Mans - CHG	Le Mans	France	10
Lyon - URCOT	Lyon	France	1
Marseille - APHM	Marseille	France	6
Marseille - Hôpital Européen	Marseille	France	4
Morlaix - CH	Morlaix	France	1
Nouvel Hôpital Civil - Hôpitaux Universitaires de Strasbourg	Strasbourg	France	6
Orléans - CHR	Orléans	France	3
Paris - Bichat	Paris	France	4
Paris - Hôpital Cochin	Paris	France	5

Clinical trials